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Abstract
Impairment of axon transport is widespread and early event in a number of neurodegenerative
diseases. The goal of study is to investigate the mechanisms of retrograde axon transport
impairment in mouse spinal motoneurons after application of β-amyloid peptide (βAP) (25-35)
on the central stump of transected sciatic nerve. Retrograde fluorescent tracer Fluorogold (5%),
β AP (25-35) (10-6 M), or mix was applied to the proximal stump of the transected sciatic nerve
of mouse under the general anesthesia. At 24 hours after surgery lumbar spinal cord was
processed for  morphometric  and immunohistochemical  analysis.  The amount of  Fluorogold-
positive motoneurons at control was 1223,7±162,7 (n = 7), whereas after application of βAP(25-
35) - 393,2±85,3 (n = 5, p < 0,01), which certifies pronounced inhibition of retrograde axonal
transport. Staining with polyclonal antibodies against caspase-3 did not reveal motoneurons in
apoptotic state. Staining with monoclonal antibodies against the β AP (25-35) was negative both
at operated and intact sides of spinal cord. Thus, revealed inhibitory action of β AP (25-35) on
the retrograde axon transport is not related to apoptotic death of neurons or accumulation of β
AP  (25-35)  inside  the  neuronal  soma,  but,  evidently,  is  mediated  by  intraaxonal  effects.
Obtained data has great importance for understanding of mechanisms of Alzheimer's disease
pathogenesis.
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